Creative regulatory practices to develop stem-cell technology: the way forward for Malaysia.
Regen Med
; 17(2): 91-105, 2022 02.
Article
em En
| MEDLINE
| ID: mdl-34905952
ABSTRACT
Malaysia aspires to develop regenerative medicine through stem-cell technology. It needs a regulatory system that could facilitate development and prevent unethical practices. A comparative legal analysis on the regulation of stem-cell technology, with a focus on stem-cell research in Malaysia and selected Commonwealth countries that are experienced in regulating this complex technology, demonstrates that the selected Commonwealth countries have adopted a hybrid of different regulatory mechanisms. This paper argues that Malaysia should consider adopting a similar approach to equip relevant authorities with different regulatory mechanisms that are able to promote innovation in stem-cell research activities and cultivate a successful and profitable regenerative medicine industry in the future. Such a strategic action can produce an optimal regulatory outcome and help Malaysia to realize its aspiration.
Palavras-chave
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Medicina Regenerativa
/
Pesquisa com Células-Tronco
País/Região como assunto:
Asia
Idioma:
En
Revista:
Regen Med
Ano de publicação:
2022
Tipo de documento:
Article
País de afiliação:
Malásia